Aktuelle Urologie

Publisher: Georg Thieme Verlag

Current impact factor: 0.16

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 0.162
2013 Impact Factor 0.28
2012 Impact Factor 0.474
2011 Impact Factor 0.267
2010 Impact Factor 0.303
2009 Impact Factor 0.206
2008 Impact Factor 0.168
2007 Impact Factor 0.23
2006 Impact Factor 0.4
2005 Impact Factor 0.32
2004 Impact Factor 0.119
2003 Impact Factor 0.073
2002 Impact Factor 0.09
2001 Impact Factor 0.177
2000 Impact Factor 0.181
1999 Impact Factor 0.24
1998 Impact Factor 0.189
1997 Impact Factor 0.168
1996 Impact Factor 0.194
1995 Impact Factor 0.166
1994 Impact Factor 0.154
1993 Impact Factor 0.2
1992 Impact Factor 0.189

Impact factor over time

Impact factor

Additional details

5-year impact 0.27
Cited half-life 6.00
Immediacy index 0.07
Eigenfactor 0.00
Article influence 0.05
ISSN 1438-8820
OCLC 231865149
Material type Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Georg Thieme Verlag

  • Pre-print
    • Author cannot archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's post-print or Publisher's version/PDF on author's personal website immediately
    • Author's post-print in Institutional Repository and PubMed Central after 12 months embargo
    • Publisher's version/PDF can be used on author's personal website only
    • Publisher copyright and source must be acknowledged
    • Link to Publisher version (www.thieme-connect.com) must be included if article has been published online
    • Publisher last contacted on 31/03/2015
    • 'Georg Thieme Verlag' is an imprint of 'Thieme Publishing'
  • Classification

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Partial nephrectomy is the treatment of choice for clinical stage 1 renal tumours. Open partial nephrectomy is the standard operative technique. The use of minimally-invasive strategies such as laparoscopic, robot-assisted partial nephrectomy or laparoendoscopic single site (LESS) partial nephrectomy has increased in recent years. Patients/Material and Methods: In this retrospective study, patients undergoing laparoscopic partial nephrectomy between December 2008 and November 2013 were evaluated. All patients presented with renal lesions suspicious for malignancy. Operations were performed as conventional laparoscopic transperitoneal partial nephrectomies (cLPN) or LESS partial nephrectomies (LESS-PN) in SITUS technique (single incision transumbilical surgery). The aim of the study was to compare perioperative outcome parameters such as duration of surgery, time of ischaemia, complications, need for transfusion, conversion rates, changes in renal function and duration of hospital stay in both groups. Results: A total of 85 laparoscopic partial nephrectomies were performed in this study (72 cLPN and 13 LESS-PN). The average tumour size was 2.68±1.47 cm (cLPN) vs. 2.46±1.11 cm (LESS-PN). The mean duration of surgery was 175.17±50.026 min (cLPN) and 185.77±35.991 min (LESS-PN). 45 (62.5%) operations (cLPN) vs. 10 (76.9%) (LESS-PN) were performed in zero-ischaemia technique. There were no significant differences in perioperative outcome parameters between both groups. Postoperative complication rates (Clavien-Dindo≥3) were 11.1% (cLPN) vs. 7.7% (LESS-PN). Conclusions: LESS partial nephrectomy in SITUS technique is an attractive alternative to conventional laparoscopic and open partial nephrectomy.
    Aktuelle Urologie 11/2015; 46(6). DOI:10.1055/s-0041-106151
  • [Show abstract] [Hide abstract]
    ABSTRACT: The era of cytokines, given to patients with metastatic renal cell carcinoma (mRCC) as part of an unspecific immunomodulatory treatment concept, seems to have ended with the introduction of targeted therapies. However, preliminary data from studies on treatment with checkpoint inhibitors (e. g. anti-PD-1 and anti-PD-L1) may point the way to second-generation immunotherapy. The rationale of such immunomodulatory treatment is to stop or interrupt the tumour from "escaping" the body's immune defence. Thompson et al. report that increased protein expression of PD-L1 (CD274/ B7-H1) in tumour cells and tumour-infiltrating immune cells (TILs; lymphocytes and histiocytes) is associated with unfavourable clinical pathological parameters as well as poor survival. In small pilot groups of mRCC patients it was found that increased PD-L1 protein expression in tumours and TILs may be correlated with the objective response to anti-PD-1 treatment. Sometimes, however, a very wide variety of response rates was observed, which raises the question if this can be explained by individual expression levels of PD-L1 (CD 274) or PD-1 (PDCD1).Recently published data from the Cancer Genome Atlas (TCGA) Kidney Renal Clear Cell Carcinoma (KIRC) Network now provide a genome-wide data base that allows us to review or validate the molecular results obtained in clear cell renal cell carcinomas (ccRCC) to date.In this study, we analysed the TCGA KIRC mRNA expression data for PD-L1 and PD-1 for a possible association with clinical pathological parameters and the survival of 417 ccRCC patients.The mRNA expression of PD-L1 in primary nephrectomy specimens revealed no significant association with unfavourable clinical parameters. Interestingly, though, a positive correlation with patient survival was found (HR=0,59, p=0,006).These results, which partly contradict the concept applied to date, point out the necessity to ascertain the characteristics of PD-L1 and PD-1 expression at mRNA and protein level in an appropriately sized patient population and evaluate the clinical significance.
    Aktuelle Urologie 11/2015; 46(6). DOI:10.1055/s-0041-106169
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Muir-Torre syndrome (MTS) is a subtype of the Lynch syndrome (hereditary nonpolyposis colorectal cancer). In addition to tumours typically related to LS, MTS is associated with tumours of the sebaceous gland or keratoacanthoma. MTS is mostly characterised by a mutation of MSH2. In contrast to LS-associated tumours carrying a mutation of MLH1, MSH6 or PMS2, the frequency of urological neoplasms seems to be higher in Lynch syndrome patients with MSH2 mutation. Urological implications for the care of patients with LS or MTS include the early diagnosis of a possible hereditary background in patients presenting with urothelial cancers at an atypically young age and potentially the surveillance of carriers of mutations with an increased risk for urothelial cancers like males harbouring a MSH2 mutation.We report on a patient with various types of LS-associated cancers and cancers without a known association with LS, who died from multifocal metastasis of urothelial cancer. This case report shows that close interdisciplinary cooperation is mandatory for the treatment of patients with complex diseases.
    Aktuelle Urologie 10/2015; DOI:10.1055/s-0035-1559789
  • [Show abstract] [Hide abstract]
    ABSTRACT: The introduction of molecular targeted agents has started to transform the treatment of metastatic renal cell carcinoma (mRCC), leading to a significant improvement of the prognosis of patients affected by that disease. However, treatment of metastatic disease still remains challenging as almost all patients will experience tumour progression and long-term survivors are very rare. This clearly warrants a continued search for improved treatment options. In recent years, the development of new substances and treatment approaches involving the targeted activation and modulation of the immune system have moved immunotherapy back into the focus of interest. A major development is the use of checkpoint inhibitors, which enable a targeted (re)activation of T cells. The following article describes the current methods used to improve standard treatment with the established targeted substances and discusses them along with the new immunooncological approaches of checkpoint modulation in the context of the treatment of mRCC patients.
    Aktuelle Urologie 10/2015; DOI:10.1055/s-0041-106138
  • [Show abstract] [Hide abstract]
    ABSTRACT: The female urethra is probably the most neglected organ in women. Female urethral stricture and primary bladder neck obstruction are rare clinical entities. Traditional and new surgical techniques have been described for the treatment of female urethral stricture. However, they are based on limited data. There is no consensus on best management. The techniques of urethroplasty all have a higher mean success rate (80-94%) than urethral dilatation (< 50%), albeit with shorter mean follow-up. Urethroplasty performed by experienced surgeons appears to be a feasible option in women who have failed urethral dilatation, although there is a lack of high-level evidence to recommend one technique over another.Primary bladder neck obstruction (PBNO) is a condition in which the bladder neck fails to open adequately during voiding. This leads to increased striated sphincter activity or obstruction of urinary flow without another anatomic cause being present, for example an obstruction caused by genitourinary prolapse in women. Watchful waiting, pharmacotherapy and surgical intervention are possible treatments.
    Aktuelle Urologie 09/2015; 46(5):382-7. DOI:10.1055/s-0035-1559624
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic pelvic pain has a negative impact on quality of life, resulting in a tremendous cost of illness. This condition has a multifactorial etiology and its treatment is often a frustrating experience for patients and therapists alike. Therefore, patients frequently initiate alternative medical treatment methods, which are explained below.
    Aktuelle Urologie 09/2015; 46(5):388-90. DOI:10.1055/s-0035-1559650
  • [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of kidney stones is increasing worldwide. Asymptomatic non-obstructing kidney stones are increasingly detected as an incidental finding on radiologic imaging, which has been performed more frequently over the last decades. Beside the current interventional treatment modalities such as extracorporeal shockwave lithotripsy (ESWL), ureterorenoscopy (URS) and percutaneous nephrolithotomy (PNL), active surveillance of asymptomatic kidney stones has been a focus of discussion lately, not only for attending physicians, but even more so for patients. The current German and European guidelines recommend active surveillance for patients with asymptomatic kidney stones if no interventional therapy is mandatory because of pain or medical factors. Herein we review the current literature on risks and benefits of active surveillance of asymptomatic non-obstructing kidney stones.
    Aktuelle Urologie 09/2015; 46(5):391-4. DOI:10.1055/s-0035-1559651

  • Aktuelle Urologie 09/2015; 46(5):410-5. DOI:10.1055/s-0035-1564153
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cryptorchidism is the most common disorder in paediatric surgery in the Western world and a major risk factor for subfertility and malignancy. In 2009, German national guidelines were changed to recommend that treatment for undescended testes should be completed by the age of 1 instead of 2. However, the share of boys undergoing orchidopexy for cryptorchidism within the first year of life has only marginally increased in response to the guideline of the Association of the Scientific Medical Societies in Germany (AWMF). The number of orchidopexies performed in children below the age of 1 is too low both in Germany as well as internationally. The majority of primary care physicians treating children do not seem to be aware of this discrepancy between guideline recommendations and average actual age at orchidopexy. Moreover, a considerable number of cryptorchidism cases seem to be due to secondary ascent of the testis - an underappreciated condition that usually occurs at school age. Consequently, the timing of orchidopexy in primary undescended testes must be optimised. Therefore, education of parents and primary care physicians regarding the necessity of early orchidopexy and frequent testicular examinations even beyond infancy is mandatory to improve the prognosis of cryptorchidism regarding subfertility and malignancy. Further studies are needed to clarify the reasons for the large number of late orchidopexies.
    Aktuelle Urologie 09/2015; 46(5):373-377. DOI:10.1055/s-0035-1555801
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Detection of changes in cognition after transurethral resection (TURP) or 180-Watt green-light XPS laser treatment (GLL) of the prostate is required by the German "Krankenhausbedarfsplan" which demands an interdisciplinary dialogue including special aspects of the operating discipline. This has as yet not been investigated in Germany or in Europe. Methods: Assessments of the cognitive capacity were made by application of the "Mini Mental State Examination" and the "Uhrentest" preoperatively and on postoperative day 2 in addition to documentation of clinical parameters such as patient age, prostate size, duration of surgery, comorbidities, co-medication, changes in haemoglobin and sodium. Results: Patients treated with transurethral resection (n=88) or GLL (n=114) were comparable regarding age, prostate size and operative time. Baseline characteristics of the patients who would be treated with laser showed an increased potential for postoperative cognitive changes: they had an average of 3.8 comorbidities (TURP: 3.11, p=0.005) and were to a greater extent using multiple medications 6.79 (TURP: 5.24, p<0.001). However neither the MMSE nor Uhrentest demonstrated a decrease in the average postoperative score (difference post-preop. MMSE+0.6±1.6 for the GLL and+0.6±1.6 for TURP, p=0.944; difference post- and preoperative Uhrentest+0.43±1.44 for the GLL and 0.13±1.17 for the TURP, p=0.097). Neither the postoperative haemoglobin nor the postoperative sodium, as safety-relevant parameters, demonstrated clinically relevant changes. The differences between the surgical procedures were not statistically significant. 28.6% of the patients with a preoperatively impaired cognition measured by an MMSE-score of≤23.7 incurred a further decline of their cognitive capability in comparison with patients without preoperative cognitive impairment with a further decline in 19.2%. Conclusions: Neither the GLL nor transurethral prostate resection demonstrated changes in cognition by comparing the preoperative Mini Mental State Examination or the Uhrentest. In this study, the baseline characteristics of lasered patients showed a higher number of comorbidities and a higher use of medication, in particular, with anticholinergic potency. Patients with a preoperatively impaired cognition had an increased risk of further worsening of their cognitive capabilities and should be treated carefully. © Georg Thieme Verlag KG Stuttgart · New York.
    Aktuelle Urologie 08/2015; DOI:10.1055/s-0035-1550031
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Behavioral interventions are part of the standard therapy for the overactive bladder syndrome although its impact still is unclear. Methods: A systematic review according to the key words "overactive bladder" and "behavioral therapy" was undertaken. Original studies dealing with adults and with an English abstract were taken into consideration. Results: Due to these requirements, only 6 studies were found. They use behavioral interventions as single therapy or compare a behavioral intervention with a standard drug therapy. On the one hand this was a direct comparison to a therapy with antimuscarinics, on the other hand drug therapy was augmented by behavioral interventions if the primary therapy failed. Inclusion criteria, patient characteristics, methods of behavioral intervention, the kind of media used and the results were inconsistent. As a result behavioral interventions are considered to be effective in controlling symptoms of an overactive bladder; in some studies an additive effect to drug therapy is seen if behavioral interventions are performed as supplementary measure; other studies could not confirm such an effect. Conclusion: Although experimental studies about micturition control in the CNS make a positive effect of behavioral interventions in overactive bladder more than likely, the literature reports on this topic remain inhomogeneous. © Georg Thieme Verlag KG Stuttgart · New York.
    Aktuelle Urologie 08/2015; 46(5). DOI:10.1055/s-0035-1550037

  • Aktuelle Urologie 08/2015; 46(4):312-21. DOI:10.1055/s-0035-1559637

  • Aktuelle Urologie 08/2015; 46(4):322-9. DOI:10.1055/s-0035-1559638
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sexual functional dysfunctions represent a multidimensional nosological entity. Apart from the directly measurable pathophysiological parameters, psychological and dynamic partnership aspects are almost always involved. These can exert a triggering and a potentiating influence. Similarly, sociocultural factors have to be taken into account. In men the problem most frequently has a physiological focus and the main symptom within the complex of sexual difficulties, especially for diabetic patients, is erectile dysfunction. Disorders of ejaculation and orgasm may also occur. Testosterone production in men may be impaired due to obesity-related dysfunctions of the hypothalamic-pituitary-gonadal axis and this can lead to a clinically significant androgen deficit and thus also to a decline of libido 1 2. © Georg Thieme Verlag KG Stuttgart · New York.
    Aktuelle Urologie 07/2015; 46(4):303-308. DOI:10.1055/s-0035-1555797
  • [Show abstract] [Hide abstract]
    ABSTRACT: A scrotal mass as initial manifestation of necrotising pancreatitis is very rare. In addition, the diagnosis is very difficult because diseases that occur more frequently produce similar symptoms. Therefore, it is very important to think about rare entities in the differential diagnosis for testicular pain. © Georg Thieme Verlag KG Stuttgart · New York.
    Aktuelle Urologie 07/2015; 46(4):309-310. DOI:10.1055/s-0035-1548877

  • Aktuelle Urologie 06/2015; 46(3):187-90. DOI:10.1055/s-0035-1555687

  • Aktuelle Urologie 06/2015; 46(3):194-5. DOI:10.1055/s-0035-1555691
  • H Rexer ·

    Aktuelle Urologie 06/2015; 46(3):204. DOI:10.1055/s-0035-1555699